title: Topical 0.03% tacrolimus for treatment of pemphigus erythematosus in a Korea Jindo dog.
abstract: Topical 0.03% tacrolimus was used for treatment of a Korea Jindo dog diagnosed with pemphigus erythematosus. The dog was slowly improved following application of tacrolimus but did not achieve complete remission until end of this study. No adverse effects on clinical or laboratory parameters were noted during the topical tacrolimus therapy period.
authors.affiliation: Department of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, South Korea.
authors.forename: Dong-Ha
authors.initials: DH
authors.lastname: Bhang
authors.forename: Ul-Soo
authors.initials: US
authors.lastname: Choi
authors.forename: Yun-Chan
authors.initials: YC
authors.lastname: Jung
authors.forename: Min-Kyu
authors.initials: MK
authors.lastname: Kim
authors.forename: Eun-Wha
authors.initials: EW
authors.lastname: Choi
authors.forename: Kyoung-Won
authors.initials: KW
authors.lastname: Seo
authors.forename: Min-Soo
authors.initials: MS
authors.lastname: Kang
authors.forename: Cheol-Yong
authors.initials: CY
authors.lastname: Hwang
authors.forename: Dae-Yong
authors.initials: DY
authors.lastname: Kim
authors.forename: Hwa-Young
authors.initials: HY
authors.lastname: Youn
authors.forename: Chang-Woo
authors.initials: CW
authors.lastname: Lee
mesh_terms: D000287:Administration, Topical; D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D012867:Skin / Q000473:pathology; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus